Potential inhibitory effect of highland barley protein hydrolysates on the formation of advanced glycation end-products (AGEs): A mechanism study.

Advanced glycation end products (AGEs) can be caused during a glycoxidation reaction. This reaction is associated with complications of diabetes and the consequences of health problems. Therefore, we are exploring the prohibitory effect of highland barley protein hydrolysates (HBPHs) on AGE formation. Herein, first extracted the protein from highland barley with various pH conditions and then hydrolyzed using four different proteolytic enzymes (flavourzyme, trypsin, papain, pepsin) under different degrees of hydrolysis. We assessed three degrees of hydrolysates (lowest, middle, highest) of enzymes used to characterize the antioxidant activity and physicochemical properties. Among all the hydrolysates, flavourzyme-treated hydrolysates F-1, F-2, and F-3 indicated the high ability to scavenge DPPH (IC50 values of 0.97 %, 0.63 %, and 0.90 %), structural and functional properties. Finally, the inhibitory effect of the most active hydrolysates F-1, F-2, and F-3 against the AGEs formation was evaluated in multiple glucose-glycated bovine serum albumin (BSA) systems. Additionally, in a BSA system, F-3 exhibited the strong antiglycation activity, effectively suppressed the non-fluorescent AGE (CML), and the fructosamine level. Moreover, it decreased carbonyl compounds while also preventing the loss of thiol groups. Our results would be beneficial in the application of the food industry as a potential antiglycation agent for several chronic diseases.

Functional bacterial cellulose nanofibrils with silver nanoparticles and its antibacterial application.

Bacterial cellulose (BC) with good biocompatibility and superior mechanical properties has broad applications. BC functionalized with silver nanoparticles (AgNPs) has been assessed as an antimicrobial membrane for wound-healing treatment. During the AgNPs synthesis, avoiding the use of toxic chemicals is very necessary for the development of environmentally friendly procedures. Herein, a Komagataeibacter xylinus-based direct biosynthetic method to fabricate D-Saccharic acid potassium salt (SA)-grafted BC (SABC) through in situ bacterial metabolism was firstly explored. Subsequently, the SABC pellicles were immersed in AgNO3 solution for ion-exchanged process, and the silver nanoparticles (AgNPs) with diameter of ∼25.2 nm were in situ synthesized on SABC nanofiber surfaces by thermal reduction instead of using a reducing agent. The morphology and microstructure of SABC/AgNPs pellicles were analyzed by field-emission scanning electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, and X-ray photoelectron spectra. Moreover, antibacterial activity measurement performed against the Gram-negative Escherichia coli (E. coli) and Gram-positive Staphylococcus aureus (S. aureus) by disk diffusion and plate count methods, showed high-efficiency bacteria-killing performance of SABC/AgNPs pellicles. This work proposed a new method by using microbial metabolism to prepare BC pellicles with functional groups, and antimicrobial films containing AgNPs was prepared by thermal reduction, exhibiting valuable prospects in wound healing treatment.

A novel hypoglycemic agent: polysaccharides from laver (Porphyra spp.).

Type-II diabetes mellitus (T2DM) has become one of the most prevalent diseases on Earth and some treatments have been developed to manage it. One intestinal enzyme α-amylase can break down starch to glucose. Inhibiting its activity will control blood glucose and provide an essential approach for the management of T2DM. Alpha-amylase inhibitor (α-AI) specifically inhibits the activity of α-amylase, and reduces the blood glucose level efficiently. To develop a novel α-AI, the red seaweed laver (Porphyra spp.) was exploited in this work, whose extracts contain polysaccharides showing an inhibitory effect against α-amylase. The crude polysaccharides were extracted using hot water (85 °C) and degraded to low-molecular-weight polysaccharides with 7% of H2O2. One polysaccharide PD-1 exhibiting a competitive binding mode with an IC50 of 12.72 mg mL-1 was separated from these degraded polysaccharides, showing approximately 98.78% of α-amylase inhibition activity. In vivo, PD-1 could efficiently suppress postprandial blood glucose levels in normal and diabetic rats. The polysaccharide inhibitor from red seaweed laver could be regarded as a novel functional food ingredient in T2DM management.